Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjelika Gasilina

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bio-Protocol|October 31, 2022
<i>In vitro</i> Fluorescence Imaging-based Actin Bundling AssayAnjelika Gasilina, Paul A Randazzo
Biochimica Et Biophysica Acta. Molecular Cell Research|November 14, 2021
Control of cell signaling by Arf GTPases and their regulators: Focus on links to cancer and other GTPase familiesPei-Wen Chen, Anjelika Gasilina, Mukesh P Yadav, et al.
Iscience|December 1, 2019
The ArfGAP ASAP1 Controls Actin Stress Fiber Organization via Its N-BAR DomainAnjelika Gasilina, Teresa Vitali, Ruibai Luo, et al.
The Journal of Biological Chemistry|February 10, 2022
A lysine-rich cluster in the N-BAR domain of ARF GTPase-activating protein ASAP1 is necessary for binding and bundling actin filamentsAnjelika Gasilina, Hye-Young Yoon, Xiaoying Jian, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 5, 2022
ERK phosphorylation is dependent on cell adhesion in a subset of pediatric sarcoma cell linesHye-Young Yoon, Ben Y Maron, Sofia Girald-Berlingeri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2013
Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growthSwagata Karkare, Rishi Raj Chhipa, Jane Anderson, et al.
Plos One|March 13, 2020
IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer modelsAnjelika Gasilina, Gurdat Premnauth, Purujit Gurjar, et al.
Leukemia|October 29, 2021
Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemiaShailaja Hegde, Anjelika Gasilina, Mark Wunderlich, et al.
JCI Insight|February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomesLynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bio-Protocol|October 31, 2022
<i>In vitro</i> Fluorescence Imaging-based Actin Bundling AssayAnjelika Gasilina, Paul A Randazzo
Biochimica Et Biophysica Acta. Molecular Cell Research|November 14, 2021
Control of cell signaling by Arf GTPases and their regulators: Focus on links to cancer and other GTPase familiesPei-Wen Chen, Anjelika Gasilina, Mukesh P Yadav, et al.
Iscience|December 1, 2019
The ArfGAP ASAP1 Controls Actin Stress Fiber Organization via Its N-BAR DomainAnjelika Gasilina, Teresa Vitali, Ruibai Luo, et al.
The Journal of Biological Chemistry|February 10, 2022
A lysine-rich cluster in the N-BAR domain of ARF GTPase-activating protein ASAP1 is necessary for binding and bundling actin filamentsAnjelika Gasilina, Hye-Young Yoon, Xiaoying Jian, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 5, 2022
ERK phosphorylation is dependent on cell adhesion in a subset of pediatric sarcoma cell linesHye-Young Yoon, Ben Y Maron, Sofia Girald-Berlingeri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 2013
Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growthSwagata Karkare, Rishi Raj Chhipa, Jane Anderson, et al.
Plos One|March 13, 2020
IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer modelsAnjelika Gasilina, Gurdat Premnauth, Purujit Gurjar, et al.
Leukemia|October 29, 2021
Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemiaShailaja Hegde, Anjelika Gasilina, Mark Wunderlich, et al.
JCI Insight|February 15, 2017
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomesLynn H Lee, Anjelika Gasilina, Jayeeta Roychoudhury, et al.
Pageof 1